Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for GH Research PLC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 8:34 pm Sale | 2023-12-31 | 13G | GH Research PLC GHRS | Venrock Healthcare Capital Partners II, L.P. | 1,318,327 2.500% | -2,198,798 (-62.52%) | Filing |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | GH Research PLC GHRS | Venrock Healthcare Capital Partners II, L.P. | 3,517,125 6.800% | 696,624 (+24.70%) | Filing |
| 2022-05-27 4:05 pm Purchase | 2022-05-17 | 13G | GH Research PLC GHRS | Venrock Healthcare Capital Partners II, L.P. | 2,820,501 5.400% | 2,820,501 (New Position) | Filing |